GBA Presents: RADIO SAVANT-!

[vanzandt]

What was that bio stock we played when it dropped to $4.50?!!!

 

[stonedinvestor]

If Polaris clears $112 today it will run<-------

I'll check back at he close and hope for the best.... Looks like it wants to turn up.

 

[stonedinvestor]

What was that bio stock we played when it dropped to $4.50?!!!

Bluebird people still like it. News soon. Not in.

 

[stonedinvestor]

bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real Time Price.
4.4450-0.1350 (-2.95%)
As of 12:03PM EDT.

 

[vanzandt]

Bluebird people still like it. News soon. Not in.

No, that wasn't it... I could have swore it was biomarin... i wonder if they did a reverse split because the chart shows a huge drop, but its from $120 to $74 2 years ago.

 

[vanzandt]

No, that wasn't it... I could have swore it was biomarin... i wonder if they did a reverse split because the chart shows a huge drop, but its from $120 to $74 2 years ago.

We talked about it quite a bit, ted was in too... thats gonna drive me crazy now.

 

[vanzandt]

HA!!!!!
Got it...
Amarin
AMRN
$1.36 now

 

[TrailerParkTed]

CNBC will of course delay any announcement.
I better turn on C-SPAN and see what your boy Joe is blabbing about.
From his room with the fireplace.

Hey what is PGY Ted?
I have been seeing it scroll by quite a lot lately on the 52 week high scanner.
PGY $14.48

No idea, another heavily shorted stock like RDBX? I watched it go nuts while playing TSLA. $5 to $12, thought about jumping in but the spread was too wide.

 

[vanzandt]

American Eagle call volume above normal and directionally bullish 11:45 AEO Bullish option flow detected in American Eagle with 6,647 calls trading, 6x expected, and implied vol increasing over 3 points to 59.89%. 7/29 weekly 11.5 calls and 7/29 weekly 12 calls are the most active options, with total volume in those strikes near 5,600 contracts. The Put/Call Ratio is 0.22. Earnings are expected on September 1st.

Same CEO as DBI btw.

 

[stonedinvestor]

HA!!!!!
Got it...
Amarin
AMRN
$1.36 now

The fish oil guys?

TRY THIS ONE--! IFRX--

Raymond James 12:26 IFRX Raymond James analyst Steven Seedhouse tells investors in a research note that InflaRx, which is requesting emergency use authorization from the FDA for C5a antibody vilobelimab for critically ill COVID patients, has a "legitimate shot" with the EUA given the unmet need in critically ill patients. Additionally, Seedhouse, who made no change to his Strong Buy rating, says that an EUA would be a major win for InflaRx, as it would provide financial stability, an expanded real world safety database, and act as validation from FDA regarding the pharmacologic activity of the antibody.

6 mil traded!!!!!!>>>>

IFRX
1.9300+0.5400(+38.8489%)<---
As of 12:57PM EDT.